#How Has The Carrier Screening Market Growth Evolved From 2024 To 2025
Healthcare Services

Critical Market Drivers Shaping the Outlook for Carrier Screening Market from 2025-2034: Rising Incidence Of Fetal Chromosomal Abnormalities Fuels Growth In The Carrier Screening Market

Discover trends, market shifts, and competitive outlooks for the carrier screening industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Carrier Screening Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent times, there has been a swift expansion in the size of the carrier screening market. The industry, which is projected to expand from $2.72 billion in 2024 to $3.17 billion in 2025, will demonstrate a compound annual growth rate (CAGR) of 16.4%. Factors such as heightened awareness of genetic disorders, an increase in maternal age, understanding of family planning and pregnancy, efforts to prevent genetic diseases, public health drive, and increased attention on inherited conditions are responsible for the growth experienced in the historical period.

In the forthcoming years, the carrier screening market is predicted to experience robust expansion and might reach a valuation of $5.76 billion by 2029, boasting a compound annual growth rate (CAGR) of 16.2%. The anticipated growth can be linked to developments in precision medicine, an increase in panel offerings, popularity of consumer genomics and individual testing, a focus on unusual and exceptionally rare diseases, and support from the government and insurance sectors. The integration of pharmacogenomics is also a considerable contributing factor. During the forecast period, advancements in genetic technologies, incorporation with prenatal testing, rise of personalized medicine, and services like counseling and education are the major trends. Ethical and legal predicaments will also play crucial roles.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7952&type=smp

What Are the Core Growth Drivers Propelling the Carrier Screening Market Forward?

The rise in fetal chromosomal irregularities and genetic conditions is predicted to spur the expansion of the carrier screening market in the future. Fetal chromosomal irregularities denote a fetus bearing an unusual number of chromosomes, or unusual DNA amounts within a chromosome. Chromosomal abnormality prenatal tests are designed to give a precise evaluation of a patient’s likelihood of bearing a fetus with a chromosomal condition. For instance, as per the World Health Organization’s estimate in February 2022, about 240,000 newborns lose their lives in the initial 28 days every year due to birth defects. Further, birth defects result in the death of another 170,000 children aged between 1 month and 5 years. Further, as per a report published by the United Nations Government in March 2022, it is estimated that Down syndrome affects 1 in every 1,000 to 1 in 1,100 live births globally. The annual count of children born with this chromosomal disorder ranges between 3,000 and 5,000. Therefore, the increment of fetal chromosomal anomalies and genetic disorders is the impetus behind the growth of the carrier screening market.

What Segment Types Define the Carrier Screening Market Structure?

The carrier screening market covered in this report is segmented –

1) By Type: Expanded Carrier Screening, Targeted Disease Carrier Screening

2) By Medical Condition: Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Other Medical Conditions

3) By Technology: DNA Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies

4) By End User: Hospitals, Reference Laboratories, Physician Offices And Clinics, Other End Users

Subsegments:

1) By Expanded Carrier Screening: Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS) Panels, Comprehensive Carrier Screening Tests

2) By Targeted Disease Carrier Screening: Single Gene Tests, Disease-Specific Panels, Ethnic Or Population-Specific Screening Tests

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7952&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Carrier Screening Market?

North America was the largest region in the carrier screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theCarrier Screening Industry Evolution?

Dominant businesses in the carrier screening market are concentrating on innovation in product development, such as family screening tests, to maintain their market position. Carrier screening tests are medical procedures conducted on individuals who show no signs of a specific disease or condition. For example, in June 2023, Blueprint Genetics, a Finnish company that specializes in genetic testing and diagnostics, launched a new product named the Screening Tests family. This product is tailored for specific uses like pregnancy, family planning, and exhaustive health evaluations for people without any symptoms. The goal is to recognize any elevated risks, enabling people to make knowledgeable decisions about family planning and their health. Blueprint Genetics is committed to providing actionable information to support proactive decision-making based on familiar options, highlighting their dedication to assisting individuals make informed choices about their future health.

View the full report here:

https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

What Is the Definition of the Carrier Screening Market?

Carrier screening refers to a type of genetic test that can determine if there is a gene that causes certain genetic illnesses. The carrier screening is used to identify people who have one copy of a gene mutation that produces a hereditary illness when two copies are present.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7952

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *